Literature DB >> 34135508

Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.

Erica Dalla1,2,3,4, Andrew M Leader5,6,7, Jessica LeBerichel5,6,7, María Casanova-Acebes8,9,10,11, Jovan Nikolic12, Blanca M Morales13, Markus Brown13, Christie Chang5,6,7, Leanna Troncoso5,6,7, Steven T Chen5,6,7, Ana Sastre-Perona14,15, Matthew D Park5,6,7, Alexandra Tabachnikova5,6,7, Maxime Dhainaut6,7,16, Pauline Hamon5,6,7, Barbara Maier5,6,7,17, Catherine M Sawai18, Esperanza Agulló-Pascual19, Markus Schober14, Brian D Brown6,7,16,20, Boris Reizis21, Thomas Marron5,6,7,1,22, Ephraim Kenigsberg6,20, Christine Moussion13, Philippe Benaroch12, Julio A Aguirre-Ghiso5,6,7,1,2,3,4, Miriam Merad23,24,25,26.   

Abstract

Macrophages have a key role in shaping the tumour microenvironment (TME), tumour immunity and response to immunotherapy, which makes them an important target for cancer treatment1,2. However, modulating macrophages has proved extremely difficult, as we still lack a complete understanding of the molecular and functional diversity of the tumour macrophage compartment. Macrophages arise from two distinct lineages. Tissue-resident macrophages self-renew locally, independent of adult haematopoiesis3-5, whereas short-lived monocyte-derived macrophages arise from adult haematopoietic stem cells, and accumulate mostly in inflamed lesions1. How these macrophage lineages contribute to the TME and cancer progression remains unclear. To explore the diversity of the macrophage compartment in human non-small cell lung carcinoma (NSCLC) lesions, here we performed single-cell RNA sequencing of tumour-associated leukocytes. We identified distinct populations of macrophages that were enriched in human and mouse lung tumours. Using lineage tracing, we discovered that these macrophage populations differ in origin and have a distinct temporal and spatial distribution in the TME. Tissue-resident macrophages accumulate close to tumour cells early during tumour formation to promote epithelial-mesenchymal transition and invasiveness in tumour cells, and they also induce a potent regulatory T cell response that protects tumour cells from adaptive immunity. Depletion of tissue-resident macrophages reduced the numbers and altered the phenotype of regulatory T cells, promoted the accumulation of CD8+ T cells and reduced tumour invasiveness and growth. During tumour growth, tissue-resident macrophages became redistributed at the periphery of the TME, which becomes dominated by monocyte-derived macrophages in both mouse and human NSCLC. This study identifies the contribution of tissue-resident macrophages to early lung cancer and establishes them as a target for the prevention and treatment of early lung cancer lesions.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34135508      PMCID: PMC8923521          DOI: 10.1038/s41586-021-03651-8

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  45 in total

1.  Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages.

Authors:  Christoph Schneider; Samuel P Nobs; Michael Kurrer; Hubert Rehrauer; Christoph Thiele; Manfred Kopf
Journal:  Nat Immunol       Date:  2014-09-28       Impact factor: 25.606

2.  Energy intakes and low-fat diets in children with cystic fibrosis.

Authors:  P B Pencharz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

3.  Fate mapping analysis reveals that adult microglia derive from primitive macrophages.

Authors:  Florent Ginhoux; Melanie Greter; Marylene Leboeuf; Sayan Nandi; Peter See; Solen Gokhan; Mark F Mehler; Simon J Conway; Lai Guan Ng; E Richard Stanley; Igor M Samokhvalov; Miriam Merad
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

4.  Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.

Authors:  Jerome C Martin; Christie Chang; Gilles Boschetti; Ryan Ungaro; Mamta Giri; John A Grout; Kyle Gettler; Ling-Shiang Chuang; Shikha Nayar; Alexander J Greenstein; Marla Dubinsky; Laura Walker; Andrew Leader; Jay S Fine; Charles E Whitehurst; M Lamine Mbow; Subra Kugathasan; Lee A Denson; Jeffrey S Hyams; Joshua R Friedman; Prerak T Desai; Huaibin M Ko; Ilaria Laface; Guray Akturk; Eric E Schadt; Helene Salmon; Sacha Gnjatic; Adeeb H Rahman; Miriam Merad; Judy H Cho; Ephraim Kenigsberg
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

5.  Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.

Authors:  Daigo Hashimoto; Andrew Chow; Clara Noizat; Pearline Teo; Mary Beth Beasley; Marylene Leboeuf; Christian D Becker; Peter See; Jeremy Price; Daniel Lucas; Melanie Greter; Arthur Mortha; Scott W Boyer; E Camilla Forsberg; Masato Tanaka; Nico van Rooijen; Adolfo García-Sastre; E Richard Stanley; Florent Ginhoux; Paul S Frenette; Miriam Merad
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

Review 6.  Regulation of macrophage development and function in peripheral tissues.

Authors:  Yonit Lavin; Arthur Mortha; Adeeb Rahman; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

7.  A lineage of myeloid cells independent of Myb and hematopoietic stem cells.

Authors:  Christian Schulz; Elisa Gomez Perdiguero; Laurent Chorro; Heather Szabo-Rogers; Nicolas Cagnard; Katrin Kierdorf; Marco Prinz; Bishan Wu; Sten Eirik W Jacobsen; Jeffrey W Pollard; Jon Frampton; Karen J Liu; Frederic Geissmann
Journal:  Science       Date:  2012-03-22       Impact factor: 47.728

8.  Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.

Authors:  Wen Xue; Etienne Meylan; Trudy G Oliver; David M Feldser; Monte M Winslow; Roderick Bronson; Tyler Jacks
Journal:  Cancer Discov       Date:  2011-06-16       Impact factor: 39.397

Review 9.  Tumour-associated macrophages as treatment targets in oncology.

Authors:  Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675

10.  Human and Mouse Transcriptome Profiling Identifies Cross-Species Homology in Pulmonary and Lymph Node Mononuclear Phagocytes.

Authors:  Sonia M Leach; Sophie L Gibbings; Anita D Tewari; Shaikh M Atif; Brian Vestal; Thomas Danhorn; William J Janssen; Tor D Wager; Claudia V Jakubzick
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.423

View more
  51 in total

Review 1.  Myeloid cell-targeted therapies for solid tumours.

Authors:  Sangeeta Goswami; Swetha Anandhan; Deblina Raychaudhuri; Padmanee Sharma
Journal:  Nat Rev Immunol       Date:  2022-06-13       Impact factor: 53.106

Review 2.  Clinical relevance of tumour-associated macrophages.

Authors:  Mikael J Pittet; Olivier Michielin; Denis Migliorini
Journal:  Nat Rev Clin Oncol       Date:  2022-03-30       Impact factor: 66.675

3.  Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma.

Authors:  Daniel J Gross; Navin K Chintala; Raj G Vaghjiani; Rachel Grosser; Kay See Tan; Xiaoyu Li; Jennie Choe; Yan Li; Rania G Aly; Katsura Emoto; Hua Zheng; Joseph Dux; Waseem Cheema; Matthew J Bott; William D Travis; James M Isbell; Bob T Li; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2021-10-08       Impact factor: 15.609

4.  TREM2 macrophages induced by human lipids drive inflammation in acne lesions.

Authors:  Tran H Do; Feiyang Ma; Priscila R Andrade; Rosane Teles; Bruno J de Andrade Silva; Chanyue Hu; Alejandro Espinoza; Jer-En Hsu; Chun-Seok Cho; Myungjin Kim; Jingyue Xi; Xianying Xing; Olesya Plazyo; Lam C Tsoi; Carol Cheng; Jenny Kim; Bryan D Bryson; Alan M O'Neill; Marco Colonna; Johann E Gudjonsson; Eynav Klechevsky; Jun Hee Lee; Richard L Gallo; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  Sci Immunol       Date:  2022-07-22

5.  FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.

Authors:  Grace Orstad; Gabriela Fort; Timothy J Parnell; Alex Jones; Chris Stubben; Brian Lohman; Katherine L Gillis; Walter Orellana; Rushmeen Tariq; Olaf Klingbeil; Klaus Kaestner; Christopher R Vakoc; Benjamin T Spike; Eric L Snyder
Journal:  Dev Cell       Date:  2022-07-13       Impact factor: 13.417

Review 6.  ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.

Authors:  Gennady G Yegutkin; Detlev Boison
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 7.  Oncofetal reprogramming in tumour development and progression.

Authors:  Ankur Sharma; Camille Blériot; Jennifer Currenti; Florent Ginhoux
Journal:  Nat Rev Cancer       Date:  2022-08-23       Impact factor: 69.800

Review 8.  The effects of radiation therapy on the macrophage response in cancer.

Authors:  Callum Beach; David MacLean; Dominika Majorova; James N Arnold; Monica M Olcina
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

9.  Targeting resident macrophages in cancer.

Authors:  Xin Li; Kavita Rawat; Claudia V Jakubzick
Journal:  Nat Immunol       Date:  2021-09       Impact factor: 31.250

10.  Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC.

Authors:  Kwan Ho Tang; Shuai Li; Kwok-Kin Wong; Benjamin G Neel; Alireza Khodadadi-Jamayran; Jayu Jen; Han Han; Kayla Guidry; Ting Chen; Yuan Hao; Carmine Fedele; John A Zebala; Dean Y Maeda; James G Christensen; Peter Olson; Argus Athanas; Cynthia A Loomis; Aristotelis Tsirigos
Journal:  Cancer Discov       Date:  2021-08-05       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.